ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625603 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625603; 2) Community: the network communities that were significantly associated with the response to NSC 625603; 3) Molecule: the relationships between components within communities and NSC 625603; 4) MDR: the compounds that were significantly associated with the NSC 625603.

NSC Compound Enrichment Correlation
NSC 700584 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-diselone, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0268790882218881 0.092057346
NSC 717067 Null 0.0268790882218881 0.090447462
NSC 720135 Null 0.0268790882218881 0.10975771
NSC 722508 2-(4-ethylpiperazinyl)3-p-methoxybenzoyl quinoxaline 0.0268790882218881 0.05031591
NSC 723531 Resveratrol-3,5-diacetate 0.0268790882218881 0.35088868
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0268790882218881 0.29388413
NSC 135758 Piperazinedione 0.0268790882218883 0.26026642
NSC 266763 2-Propenamide, N-[2-(decylsulfinyl)-1-(hydroxymethyl)ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)- 0.0268790882218883 0.076186265
NSC 287459 Cytarabine AY 0.0268790882218883 0.26956171
NSC 35580 Null 0.0268790882218883 0.066805268
Total:58  Current:36    [First] [Prev] [Next] [Last]